Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mack

Showing results (201-210 of 444) with videos related to

Pageof 45
Sort By:
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 10, 2013
The response of Arctic vegetation and soils following an unusually severe tundra fireM Syndonia Bret-Harte, Michelle C Mack, Gaius R Shaver, et al.
Clinical Lung Cancer|October 27, 2015
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) DatabasePrimo N Lara, James Moon, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2010
Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097)Suresh S Ramalingam, Chandra P Belani, Philip C Mack, et al.
American Journal of Clinical Oncology|June 3, 2009
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312Peter J Van Veldhuizen, Michael Hussey, Primo N Lara, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 26, 2014
In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623Claire L McEvoy, Natalie L Trevaskis, Glenn A Edwards, et al.
Plos One|May 9, 2014
The dimerization domain in DapE enzymes is required for catalysisBoguslaw Nocek, Anna Starus, Magdalena Makowska-Grzyska, et al.
Psychopharmacology|August 1, 1995
Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humansJ T Little, A Broocks, A Martin, et al.
Oncotarget|May 5, 2015
CDC20 maintains tumor initiating cellsQi Xie, Qiulian Wu, Stephen C Mack, et al.
The Prostate|January 26, 2007
GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanismsClifford G Tepper, Ruth L Vinall, Christopher B Wee, et al.
Ecosystems (New York, N.Y.)|May 14, 2023
Material Legacies and Environmental Constraints Underlie Fire Resilience of a Dominant Boreal Forest TypeNicola J Day, Jill F Johnstone, Kirsten A Reid, et al.
Pageof 45

Showing results (201-210 of 444) with videos related to

Sort By:
Pageof 45
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 10, 2013
The response of Arctic vegetation and soils following an unusually severe tundra fireM Syndonia Bret-Harte, Michelle C Mack, Gaius R Shaver, et al.
Clinical Lung Cancer|October 27, 2015
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) DatabasePrimo N Lara, James Moon, Mary W Redman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2010
Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097)Suresh S Ramalingam, Chandra P Belani, Philip C Mack, et al.
American Journal of Clinical Oncology|June 3, 2009
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312Peter J Van Veldhuizen, Michael Hussey, Primo N Lara, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 26, 2014
In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623Claire L McEvoy, Natalie L Trevaskis, Glenn A Edwards, et al.
Plos One|May 9, 2014
The dimerization domain in DapE enzymes is required for catalysisBoguslaw Nocek, Anna Starus, Magdalena Makowska-Grzyska, et al.
Psychopharmacology|August 1, 1995
Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humansJ T Little, A Broocks, A Martin, et al.
Oncotarget|May 5, 2015
CDC20 maintains tumor initiating cellsQi Xie, Qiulian Wu, Stephen C Mack, et al.
The Prostate|January 26, 2007
GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanismsClifford G Tepper, Ruth L Vinall, Christopher B Wee, et al.
Ecosystems (New York, N.Y.)|May 14, 2023
Material Legacies and Environmental Constraints Underlie Fire Resilience of a Dominant Boreal Forest TypeNicola J Day, Jill F Johnstone, Kirsten A Reid, et al.
Pageof 45